Article Library

Contents

Ciguatera Toxicology

• Defining the neurotoxin derived illness chronic ciguatera using markers of chronic systemic inflammatory distubances: A case/control study
  R.C. Shoemaker, et al.
  Neurotoxicol. Teratol (2010) (PDF file)
  
  
• Ciguatera: A public health perspective
  Robert Dickey, Steven Plakas
  The International Society on Toxinology (Toxicon) (Sep 2009) (PDF file)
  
  
• Chronic fatigue syndrome following a toxic exposure
  Delia Racciatti (Apr 2000) (PDF file)
  
  
• Ciguatera testing protocol
  (Sep 2009)
  
  
• "Chronic phase lipids in sera of chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), hepatitis B, and cancer with antigenic epitope resembling ciguatoxin, as assessed with MAb-CTX"
  J Clin Lab Anal (2003) (PDF file)
  
  
• "Chronic phase lipids in sera of several chronic diseases reacting with MAb-CTX (antibody to ciguatoxin)"
  Journal of Toxicology: Toxins Review (2003) (PDF file)
  
  
• Ciguatera Toxin FAQ
  (2003; 2005)
  
  
• Presentation given by Dr. Yoshitsugi Hokama at the International Symposium on Toxins and Natural Products
  (2002) (PDF file format)
  
  
• Neurotoxin Discovered in Chronic Fatigue Syndrome
  (Press release: 2002)
  
  
• The Neurology of ciguatera (PDF file format) or text-only format
  J Neurol Neurosurg Psychiatry (2001)

Endocrinology

• Elevated Neuroactive Progesterone Metabolites in Women with Chronic Fatigue Syndrome
  J Steroid Biochem Molec Biol (2000)
  
  
• Cortisol deficiency may account for elevated apoptotic cell population in patients with chronic fatigue syndrome
  (1999)
  
  

General

• Causes of Death Among Patients With Chronic Fatigue Syndrome
  Jason et al — Healthcare for Women International (2006) PDF file
  
  
• Understanding Chronic Fatigue Syndrome A National Women's Health Information Center featured article (2003)
  NOTE: This article is no longer available online. Members can request a printed version by contacting us with their postal address. (Only available to NCF members)
  
  
• Polygenic Contributions of Procoagulant Genetic Factors in Chronic Fatigue Syndrome and Related Chronic Illnesses.
  Genetics in Medicine (2002)
  
  
• Activation of the coagulation system in Gulf War Illness: a potential pathophysiologic link with chronic fatigue syndrome. A laboratory approach to diagnosis.
  Blood Coagul Fibrinolysis (2000)
  
  
• Chronic Fatigue Syndromes: A Different Approach
  (2000)
  
  
• Chronic Fatigue Syndrome (CFS) &/or Fibromyalgia (FM) as a Variation of Antiphospholipid Antibody Syndrome (APS): An Explanatory Model and Approach to Laboratory Diagnosis.
  Blood Coagulation & Fibrinolysis (1999)
  
  
• Is CFS/FM due to an undefined hypercoagulable state brought on by immune activation of coagulation? Does adding anticoagulant therapy improve CFS/FM patient symptoms?
  AACFS (1998)
  
  
• Understanding M.E. and CFS
  Nightingale Research Foundation
  
  
• The Human/Animal Interaction of Chronic Fatigue and Immune Dysfunction Syndrome: A Look At 127 Patients and Their 463 Animals
  (1998)
  
  
• Hillary Johnson Talks about Chronic Fatigue Syndrome and her book, Osler's Web
  (1996)
  
  

Immunology

• STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient
  I Najjar, et al.
  The Society for Leukocyte Biology (2010) (PDF file)
  
  
• Dr. Konstance Knox Presents STAT1 Data to Researchers and Clinicians at AACFS Conference
  AACFS Conference (2004)
  
  
• STAT1-alpha and p53 Deficiencies Are Found In Patients With Chronic Fatigue Syndrome
  Forum newsletter (2003)
  
  
• Expanded Model for RNase L Fragmentation in CFS Uncovered; The National CFIDS Foundation Announces The Use Of Elastase Inhibitors as a Potential Treatment for CFS Inovations
  Forum newsletter (2003)
  
  
• Potential Role of STAT1 in the Pathogenesis of Chronic Fatigue Syndrome
  Institute for Viral Pathogenesis (2003)
  
  
• "Biochemical Evidence for a Novel Low Molecular Weight 2-5A-Dependent RNase L in Chronic Fatigue Syndrome"
  Journal of Interferon and Cytokine Research (1997)
  
  
• Cytokine Effects on Mitochondrial Membrane Potential and Possible Mitochondrial Dysfunction in CFIDS
  (1997)
  
  
• Association Between HLA Class II Antigens and the Chronic Fatigue Immune Dysfunction Syndrome
  Clinical Infectious Diseases (1994)
  
  
• Decreased Natural Killer Cell Activity Is Associated with Severity of Chronic Fatigue Immune Dysfunction Syndrome
  Clinical Infectious Diseases (1994)

Infectious Disease

• Prevalence uof abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
  In Vivo (2004)
  
  
• Recent publications by Prof. Garth Nicolson and The Institute of Molecular Medicine
  
  
• A Preliminary 6 Month Trial of Valacyclovir (VAL) in Chronic Fatigue Syndrome (CFS) Using the Epstein-Barr Virus (EBV), Cytomegalovirus (HCMV) Paradigm
  (1998)
  
  
• Persistent Active Human Herpesvirus Six (HHV-6) Infections In Patients With Chronic Fatigue Syndrome.
  AACFS Conference (1998)
  
  
• New Cardiomyopathy: Pilot Study of Intravenous Ganciclovir in a Subset of the Chronic Fatigue Syndrome
  Infectious Disease in Clinical Practice (1997)
  
  
• Hypothesis: A Unified Theory of the Cause of Chronic Fatigue Syndrome
  Infectious Diseases in Clinical Practice (1997)
  
  
• Cardiac Involvement in Patients with Chronic Fatigue Syndrome as Documented with Holter and Biopsy Data in Birmingham, Michigan, 1991-1993
  (1997)
  
  
• Viruses and Chronic Fatigue Syndrome: Current Status
  (1995)
  
  
• SPECT Imaging of the Brain: Comparison of Findings in Patients with Chronic Fatigue Syndrome, AIDS Dementia Complex, and Major Unipolar Depression
  American Journal of Roentgenology (1994)
  
  
• Chronic Fatigue Syndrome: A possible Delayed Hazard of Pesticide Exposure
  Clinical Infectious Diseases (1994)
  
  
• Enterovirus in the Chronic Fatigue Syndrome
  Annals of Internal Medicine (1994)
  
  
• Poly(I) * Poly(C12U) Inhibits In Vitro Replication of Human Herpesvirus Type 6
  Clinical Infectious Diseases (1994)
  
  
• Subjective Reduction in Symptoms of Chronic Fatigue Syndrome Following Long-Term Treatment with a Porcine Liver Extract: A Phase 1 Trial
  Clinical Infectious Diseases (1994)
  
  
• Kutapressin Inhibits In Vitro Infection of Human Herpesvirus Type 6
  Clinical Infectious Diseases (1994)
  
  
• Results of an investigation of three clusters of chronic fatigue syndrome
  Clinical Infectious Diseases (1994)
  
  
• Closeness of Contacts Between People in Two Clusters of Chronic Fatigue Syndrome: Evidence for an Infectious Etiology?
  Clinical Infectious Diseases (1994)

Metabolism

• Exercise Capacity in Chronic Fatigue Syndrome
  Archives of Internal Medicine (2000)
  
  
• In vitro Study of Muscle Aerobic Metabolism in Chronic Fatigue Syndrome
  Journal of Chronic Fatigue Syndrome (1999)
  
  
• Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle
  Neuromuscul Disord. (1998)
  
  
• Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome
  Neuropsychobiology (1995)

Neurology

• Clinical and biochemical findings in ten patients with benign myalgic encephalomyelitis
  Ramsay and Rundle — Postgraduate Medical Journal (1979)
  
  
• Altered central nervous system signal during motor performance in chronic fatigue syndrome.
  Clin Neurophysiol. (2004)
  
  
• Blood volume and its relation to peak oxygen consumption and physical activity in patients with chronic fatigue.
  American Journal of Physiology (2002)
  
  
• The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome
  Am J Med Sci (2000)
  
  
• Abnormal Baroreflex Responses in Patients With Idiopathic Orthostatic Intolerance
  Circulation (2000)
  
  
• The Importance of Orthostatic Intolerance in the Chronic Fatigue Syndrome
  Am J Med Sci (1999)
  
  
• Circulating Blood Volume in Chronic Fatigue Syndrome
  Journal of Chronic Fatigue Syndrome (1998)
  
  
• Autonomic Nervous System Dysfunction Linked To Chronic Fatigue
  American Journal of Medicine (1997)

Patient Community News

• Letter Presented to the CFSCC
  (2000)
  
  
• GAO Criticizes CDC, NIH Handling of Chronic Fatigue Research
  (2000)
  
  

Prevalence studies

• Comparing Symptoms of Chronic Fatigue Syndrome in a Community-Based Versus Tertiary Care Sample
  Journal of Health Psychology (2003)
  
  
• A Community-Based Study of Chronic Fatigue Syndrome
  Archives of Internal Medicine (1999)
  
  
• Estimating the prevalence of chronic fatigue syndrome among nurses
  Am J Med. (1998)
  
  
• Estimating Chronic Fatigue Syndrome-Related Symptoms Among Nurses: A Preliminary Report Clinical Infectious Diseases
  (1994)
  
  

Reports: Conferences & Lectures

Conferences

• AACFS Conference 2001
  
  
• Clinical and Scientific Meeting2001
  
  
• Fatigue 2000: International Conference (oral presentations Abstracts)
  
  
• Fatigue 2000: International Conference (Poster Abstracts)
  
  
• Clinical and Scientific Meeting 1999
  
  
• AACFS Bi-Annual Conference 1999 in Boston
  
  
• Clinical and Scientific Meeting 1998
  
  
• AACFS Bi-Annual Conference 1998 (abstracts of posters)
  
  
• First World Congress on CFS and Related Disorders (1995) (and abstracts)
  
  
• International Research Conference 1992
  
  

Lectures

• Dr. Anthony Komaroff Lecture
  (December 2000)
  
  
• Dr. David Bell Lecture
  (August 1998)
  
  
• Dr. Paul Cheney
  (May 1998)
  
  
• Dr. Darryl See
  (January 1997)
  
  
• Dr. Paul Cheney Testimony
  (February 1993)
  
  

Virology

• Potential animal (zoonotic) virus identified in patients with Chronic Fatigue Syndrome, Multiple Sclerosis and Epilepsy
  (NCF Press Release: 2006)
  Click here for PDF version.
  
  
• Parainfluenza Virus-5: A new paradigm and a serious host challenge
  NCF Paper (2006)
  Click here for the PDF version.
  
  
• A novel virus (Cryptovirus) within the rubulavirus genus and uses therefor
  Dr. Steven Robbins' discovery on new virus in CFIDS, MS, and epilepsy. Patent (2002) (PDF file format)
  
  
• Various informational press releases from Global Medical Technologies
  (2004-2006) (PDF file format)
  
  
• Porcine parainfluenza virus 2 discovery
  by scientists at Bayer AG Patent (1999) (PDF file format)
  
  
• Isolation of a cytopathogenic virus from a case of porcine reproductive and respiratory syndrome (PRRS) and its characterization as parainfluenza virus type 2
  Archives of Virology (1998) (PDF file format)
  
  
• Nucleotide sequence for Cryptovirus fusion protein identified as a porcine rubulavirus
  Patent (2003) (PDF file format)
  
  
• Cryptovirus fusion sequence returns 100% match for fusion protein for SER strain of porcine parainfluenza virus
  BLAST program, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health (2004) (PDF file format)
  
  
• Nucleotide sequence for the fusion protein of porcine parainfluenza virus strain SER
  National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health (2003) (PDF file format)
  
  
• Porcine parainfluenza virus strain SER sequence doesn't return match for the Cryptovirus fusion sequence though it is a 100% match
  BLAST program, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health (2004) (PDF file format)
  
  
• Methods for diagnosis and treatment of chronic immune diseases; Stat-1 deficiency discovery in CFIDS
  (2003) Patent. (PDF file format)
  
  
• Viral mechanisms of immune evasion
  Immunology Today review paper (2000) (PDF file format)
  
  
• Silencing STATs: Lessons from paramyxovirus interferon evasion
  Cytokine and Growth Factors review paper (2004) (PDF file format)
  
  
• The V protein of Simian Virus 5 inhibits interferon signaling by targeting STAT1 for proteasome-mediated degradation
  Journal of Virology (1999) (PDF file format)
  
  
• Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures
  Journal of General Virology (2000) (PDF file format)
  
  
• Risk factors associated with Chronic Fatigue Syndrome in a cluster of pediatric cases
  Reviews of Infectious Diseases (1991) (PDF file format)
  
  
• Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5)
  Journal of General Virology (2004) (PDF file format)
  
  
• In vitro identification and characterization of a virus isolated from a dog with neurological dysfunction
  Infection and Immunity (1981) (PDF file format)
  
  
• Potential role of persistent paramyxovirus infection in Chronic Fatigue Syndrome
  Interim progress report and research proposal (2005) (PDF file format)
  
  
• Molecular Structure Of Viral Protein, Parainfluenza Virus 5 Fusion (F) Protein, Identified By Scientists At Northwestern University
  Medical News Today article (2006)